Aug. 8 at 5:45 PM
$INGN narrows Q2 loss, beats revenue estimates — but is the turnaround real? 📈
Inogen posted a narrower-than-expected adjusted loss per share of 2 cents, topping the Zacks Consensus Estimate of a 22-cent loss, with sales revenues increasing 4% year over year. Yet, the stock is still down 36% YTD despite a 2.7% pre-market rise today.
Opportunity assessment here 👉 https://www.zacks.com/stock/news/2684701/inogen-stock-gains-following-q2-earnings-beat-revenues-up-yy?cid=sm-stocktwits-2-2684701-body-7007&ADID=SYND_STOCKTWITS_TWEET_2_2684701_BODY_7007